Work With Data

Bristol Myers Squibb in the news

Updated: 97d ago

Analyze the latest Bristol Myers Squibb news, with a current slightly positive sentiment polarity (0.35) or the entire set.

Latest news

Here are the latest news on this scope:

Bristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for tariffs

Read on: CNBC News link
97d ago

Stocks making the biggest moves after hours: Tesla, Enphase Energy, Oklo, Bristol Myers Squibb and more

Read on: CNBC News link
103d ago

Bristol Myers Squibb plans $2 billion in cost cuts by 2027, issues weak guidance

Read on: CNBC News link
174d ago

Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug

Read on: CNBC News link
193d ago

Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs

Read on: CNBC News link
271d ago

Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costs

Read on: CNBC News link
372d ago

Bristol Myers Squibb Cancer-Treatment Trial Misses Endpoint

451d ago

Judge tosses Medicare drug negotiation challenges from Bristol Myers Squibb, Johnson & Johnson

Read on: The Hill link
461d ago

Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug-price negotiations

Read on: CNBC News link
462d ago

Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss

Read on: CNBC News link
466d ago

Bristol Myers Squibb drafts contingency plans for US restrictions on Chinese pharma

Read on: Financial Times link
467d ago

Healthy Returns: J&J cell therapy gains new edge over Bristol Myers rival

Read on: CNBC News link
480d ago

J&J, Merck and Bristol Myers Squibb CEOs Defend Drug Prices at Senate Hearing

543d ago

Bristol Myers Squibb results top estimates as new drugs post strong sales growth

Read on: CNBC News link
549d ago

Healthy Returns: J&J, Merck and Bristol Myers Squibb are in the hot seat

Read on: CNBC News link
552d ago

Bristol Myers Squibb to Discontinue Metastatic Colorectal Cancer Trial

598d ago

Bristol Myers to Buy Mirati Therapeutics for $4.8 Billion

Read on: Bloomberg link
665d ago

Extract data

Extract all the news on this scope:

Visualize data

Here are some available charts on these news:

Evolution through time

Distribution of sources in the news

Distribution of sections in the news

Sentiment polarity through time